Side by side with Sanofi Genzyme's commitment to patients is our commitment to the health care professionals who treat and care for them. Please reach out to us if you have any questions or concerns.
Sanofi Genzyme Medical Information is staffed with experts in our products and the diseases they treat, who are available to answer your questions. In the U.S., you can call 800-745-4447 (toll-free) or 617-768-9000, and choose option #2, Monday through Friday between 8 a.m. and 6 p.m. (EST).
If you are outside the U.S. you can use your online form to send a message to Medical Information's regional contacts:
If you have a patient taking a Sanofi Genzyme product who is experiencing side effects, please report this information to us by contacting Sanofi Genzyme Medical Information - see above for phone numbers for the U.S. and links to our online form for other regions.
In the U.S., you are encouraged to report negative side effects of prescription drugs to the FDA via its MedWatch program:
Find out more about reporting side effects to Sanofi Genzyme
Sanofi Genzyme collaborates with and supports health care professionals in many ways, from co-sponsoring clinical trials to providing research and education grants.
- Get information on our investigator-sponsored studies program
- Apply online for Sanofi Genzyme's other research and education grants
Committed to Transparency
At Sanofi Genzyme we are focused on making a difference in patients’ lives. To make tomorrow’s therapeutic solutions real, we seek to innovate with other individuals and organizations, who like us, aim to improve patient health. We work with physicians and teaching hospitals as well as patient associations and others involved in healthcare. We are fully committed to transparency; it is important to us to foster an understanding of these interactions and to prevent any real or perceived conflict of interest. As part of the federal Open Payments (Physician Payments Sunshine Act), overseen by the Centers for Medicare and Medicaid Services (CMS) any payment or transfer of value we make to a physician or teaching hospital is subject to collection and potential public reporting. These payments are separate and in addition to existing state transparency reporting requirements. We continue to be dedicated to complying with state and federal laws and regulations today and in the future.
Sanofi Genzyme is a business unit of Sanofi. See Sanofi's full Transparency statement
Sanofi Genzyme is an industry leader in providing support services and programs to help facilitate patient access to treatment, including help with understanding insurance plans, finding alternative forms of funding, and opportunities to obtain free or subsidized treatment.
Find out more about Sanofi Genzyme's patient support services
You may also want to direct your patients to Sanofigenzyme.com to explore our educational information and resources.
Sanofi Genzyme has established registries - large, often multinational databases to which physicians contribute clinical data on patients - for several lysosomal storage disorders (LSDs), to help pool knowledge and improve understanding of these rare diseases. Get more information and enroll patients online at the registries' websites:
Last Updated: 3/10/2017